Excellence in Health Care

Search menu

Search form

About Us

Orange Coast Medical Center

Orange Coast Memorial Named Screening Center of Excellence

Orange Coast Memorial Medical Center was recently named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening. Low dose CT screening for lung cancer carried out safely, efficiently and equitably saves tens of thousands of lives a year.

“In receiving this prestigious designation, we are able to set an example for responsible screening practices in Orange County and across the country,” explains Marcia Manker, CEO of OCMMC. “Lung cancer continues to be by far the leading cause of cancer death among both men and women and early and accurate detection through appropriate screening practices are critical to providing patients the best chance for beating their disease.”

LCA is leading non-profit organization dedicated to saving lives and advancing research by empowering people living with or at risk for lung cancer. LCA launched the National Framework for Excellence in Lung Cancer Screening and Continuum of Care in 2012 and now have over 250 sites committed to the guidelines. The National Framework lays out a bill of rights for the at-risk public and guiding principles for lung cancer screening sites.

“We are proud and honored to be working with Orange Coast Memorial Medical Center as a Lung Cancer Alliance Screening Center of Excellence. Their commitment to practice responsible lung cancer screening will lead to advancements in research and many lives saved. They are an example to follow,” says LCA President and CEO, Laurie Fenton Ambrose.

Designated Screening Centers of Excellence are committed to provide clear information based on current evidence on who is a candidate for lung cancer screening, and to comply with comprehensive standards based on best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP) for controlling screening quality, radiation dose and diagnostic procedures within an experienced, multi-disciplinary clinical setting.

“Low dose CT screening has shown to be the only proven method to detect lung cancer at an early and treatable stage and it is imperative that we continue to remain vigilant about who is an appropriate candidate for these screenings,” adds Dr. Jack Jacoub, medical oncologist and director of thoracic oncology at Orange Coast Memorial Medical Center. “As clinicians, we hope that this designation further validates the trust our patients and their caregivers have placed in our ability to help safely and accurately detect their disease.”